GSK plc (the 'Company')
The following amendment has been made to the Director/PDMR Shareholding announcement released on 23 June 2025 at 15.30 under RNS No 0150O.
1,350 Ordinary Shares were purchased by Lady Susan Symonds, PCA of Sir Jonathan Symonds (Non-Executive Chair).
All other details remain unchanged.
The full amended text is shown below.
GSK plc (the 'Company')
Transaction notification
|
1. |
Details of PDMR/person closely associated with them ('PCA') |
||||
|
a) |
Name |
Lady Susan Symonds |
|||
|
b) |
Position/status |
PCA of Sir Jonathan Symonds (Non-Executive Chair) |
|||
|
c) |
Initial notification/ amendment |
Initial notification |
|||
|
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
GSK plc |
|||
|
b) |
LEI |
5493000HZTVUYLO1D793 |
|||
|
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
||||
|
a) |
Description of the financial instrument |
Ordinary shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63 |
|||
|
b) |
Nature of the transaction |
Purchase of 1,350 Ordinary Shares |
|||
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
||
|
£14.3550 |
1,350 |
||||
|
d) |
Aggregated information |
N/A (single transaction) |
|||
|
Aggregated volume Price |
|||||
|
e) |
Date of the transaction |
2025-06-20 |
|||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|||
|
1. |
Details of PDMR/person closely associated with them ('PCA') |
||||
|
a) |
Name |
Wendy Becker |
|||
|
b) |
Position/status |
Independent Non-Executive Director |
|||
|
c) |
Initial notification/ amendment |
Initial notification |
|||
|
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
GSK plc |
|||
|
b) |
LEI |
5493000HZTVUYLO1D793 |
|||
|
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
||||
|
a) |
Description of the financial instrument |
Ordinary shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63 |
|||
|
b) |
Nature of the transaction |
Purchase of 545 Ordinary Shares |
|||
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
||
|
£14.3550 |
545 |
||||
|
d) |
Aggregated information |
N/A (single transaction) |
|||
|
Aggregated volume Price |
|||||
|
e) |
Date of the transaction |
2025-06-20 |
|||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|||
|
1. |
Details of PDMR/person closely associated with them ('PCA') |
||||
|
a) |
Name |
Elizabeth (Liz) McKee Anderson |
|||
|
b) |
Position/status |
Independent Non-Executive Director |
|||
|
c) |
Initial notification/ amendment |
Initial notification |
|||
|
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
GSK plc |
|||
|
b) |
LEI |
5493000HZTVUYLO1D793 |
|||
|
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
||||
|
a) |
Description of the financial instrument |
American Depositary Shares ('ADSs') ISIN: US37733W2044 |
|||
|
b) |
Nature of the transaction |
Purchase of 258 ADSs |
|||
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
||
|
$37.8958 |
258 |
||||
|
d) |
Aggregated information |
N/A (single transaction) |
|||
|
Aggregated volume Price |
|||||
|
e) |
Date of the transaction |
2025-06-20 |
|||
|
f) |
Place of the transaction |
New York Stock Exchange (XNYS) |
|||
|
1. |
Details of PDMR/person closely associated with them ('PCA') |
||||
|
a) |
Name |
Charles Bancroft |
|||
|
b) |
Position/status |
Senior Independent Non-Executive Director |
|||
|
c) |
Initial notification/ amendment |
Initial notification |
|||
|
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
GSK plc |
|||
|
b) |
LEI |
5493000HZTVUYLO1D793 |
|||
|
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
||||
|
a) |
Description of the financial instrument |
American Depositary Shares ('ADSs') ISIN: US37733W2044 |
|||
|
b) |
Nature of the transaction |
Purchase of 2,021 ADSs |
|||
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
||
|
$37.8958 |
2,021 |
||||
|
d) |
Aggregated information |
N/A (single transaction) |
|||
|
Aggregated volume Price |
|||||
|
e) |
Date of the transaction |
2025-06-20 |
|||
|
f) |
Place of the transaction |
New York Stock Exchange (XNYS) |
|||
|
1. |
Details of PDMR/person closely associated with them ('PCA') |
||||
|
a) |
Name |
Dr Hal Barron |
|||
|
b) |
Position/status |
Non-Executive Director |
|||
|
c) |
Initial notification/ amendment |
Initial notification |
|||
|
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
GSK plc |
|||
|
b) |
LEI |
5493000HZTVUYLO1D793 |
|||
|
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
||||
|
a) |
Description of the financial instrument |
American Depositary Shares ('ADSs') ISIN: US37733W2044 |
|||
|
b) |
Nature of the transaction |
Purchase of 258 ADSs |
|||
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
||
|
$37.8958 |
258 |
||||
|
d) |
Aggregated information |
N/A (single transaction) |
|||
|
Aggregated volume Price |
|||||
|
e) |
Date of the transaction |
2025-06-20 |
|||
|
f) |
Place of the transaction |
New York Stock Exchange (XNYS) |
|||
|
1. |
Details of PDMR/person closely associated with them ('PCA') |
||||
|
a) |
Name |
Dr Anne Beal |
|||
|
b) |
Position/status |
Independent Non-Executive Director |
|||
|
c) |
Initial notification/ amendment |
Initial notification |
|||
|
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
GSK plc |
|||
|
b) |
LEI |
5493000HZTVUYLO1D793 |
|||
|
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
||||
|
a) |
Description of the financial instrument |
American Depositary Shares ('ADSs') ISIN: US37733W2044 |
|||
|
b) |
Nature of the transaction |
Purchase of 257 ADSs |
|||
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
||
|
$37.8958 |
257 |
||||
|
d) |
Aggregated information |
N/A (single transaction) |
|||
|
Aggregated volume Price |
|||||
|
e) |
Date of the transaction |
2025-06-20 |
|||
|
f) |
Place of the transaction |
New York Stock Exchange (XNYS) |
|||
|
1. |
Details of PDMR/person closely associated with them ('PCA') |
||||
|
a) |
Name |
Dr Hal Dietz |
|||
|
b) |
Position/status |
Independent Non-Executive Director |
|||
|
c) |
Initial notification/ amendment |
Initial notification |
|||
|
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
GSK plc |
|||
|
b) |
LEI |
5493000HZTVUYLO1D793 |
|||
|
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
||||
|
a) |
Description of the financial instrument |
American Depositary Shares ('ADSs') ISIN: US37733W2044 |
|||
|
b) |
Nature of the transaction |
Purchase of 257 ADSs |
|||
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
||
|
$37.8958 |
257 |
||||
|
d) |
Aggregated information |
N/A (single transaction) |
|||
|
Aggregated volume Price |
|||||
|
e) |
Date of the transaction |
2025-06-20 |
|||
|
f) |
Place of the transaction |
New York Stock Exchange (XNYS) |
|||
|
1. |
Details of PDMR/person closely associated with them ('PCA') |
||||
|
a) |
Name |
Dr Jeannie Lee |
|||
|
b) |
Position/status |
Independent Non-Executive Director |
|||
|
c) |
Initial notification/ amendment |
Initial notification |
|||
|
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
GSK plc |
|||
|
b) |
LEI |
5493000HZTVUYLO1D793 |
|||
|
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
||||
|
a) |
Description of the financial instrument |
American Depositary Shares ('ADSs') ISIN: US37733W2044 |
|||
|
b) |
Nature of the transaction |
Purchase of 258 ADSs |
|||
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
||
|
$37.8958 |
258 |
||||
|
d) |
Aggregated information |
N/A (single transaction) |
|||
|
Aggregated volume Price |
|||||
|
e) |
Date of the transaction |
2025-06-20 |
|||
|
f) |
Place of the transaction |
New York Stock Exchange (XNYS) |
|||
|
1. |
Details of PDMR/person closely associated with them ('PCA') |
||||
|
a) |
Name |
Dr Vishal Sikka |
|||
|
b) |
Position/status |
Independent Non-Executive Director |
|||
|
c) |
Initial notification/ amendment |
Initial notification |
|||
|
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
GSK plc |
|||
|
b) |
LEI |
5493000HZTVUYLO1D793 |
|||
|
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
||||
|
a) |
Description of the financial instrument |
American Depositary Shares ('ADSs') ISIN: US37733W2044 |
|||
|
b) |
Nature of the transaction |
Purchase of 889 ADSs |
|||
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
||
|
$37.8958 |
889 |
||||
|
d) |
Aggregated information |
N/A (single transaction) |
|||
|
Aggregated volume Price |
|||||
|
e) |
Date of the transaction |
2025-06-20 |
|||
|
f) |
Place of the transaction |
New York Stock Exchange (XNYS) |
|||